H3D
@H3D_UCT
H3D is the first and only centre of its kind on the African continent, an integrated drug discovery and development centre with TB, malaria and AMR platforms
ID:1317771709076865025
18-10-2020 10:17:30
631 Tweets
809 Followers
168 Following
Proud of this comment article in nature jointly written by H3D & Ersilia. We discuss how (low-data) AI can aid pharmacogenetics in Africa. We are actively working on this, so there's more to come!
Thanks Gemma Turon Kelly Chibale Mwila & Mathew!
nature.com/articles/d4158…
In this #DrugDiscoveryToday review, Vinayak Singh describes strategies for shortening the intolerably long treatment regimens for #TB (currently 4–9 months for subsceptible strains!), important both for patients and global TB management: sciencedirect.com/science/articl… 💊 UCT IDM
Join us for our next webinar this Wednesday at 2pm (SAST)
Dr Tai Yue from Medicines for All will be presenting on pharmaceutical process chemistry.
Join via this Microsoft Teams: lnkd.in/d6yEnFhB
Info: [email protected] or [email protected]
New paper in #ACSMedChemLett ! To address the cardiotoxicity of the antimalarial astemizole, Dickson Mambwe et al. report a compound with multistage activity and a >6 000-fold selectivity against hERG relative to astemizole. No cross-resistance was observed pubs.acs.org/doi/10.1021/ac…
Today, we mark #WorldTuberculosisDay .
An initiative of World Health Organization (WHO), the theme for #WorldTBDay2024 is ‘Yes! You and I Can End TB’.
As avid supporters of TB drug discovery research, this is a statement we firmly believe in and strive to realise.
Read more:
h3dfoundation.org/world-tb-day-h…
Maximise your chances of getting your medicinal chemistry-based manuscript accepted for publication! In a new editorial in #ACSMedChemLett , Editor-in-Chief Kelly Chibale and John Woodland share their top tips for prospective authors: pubs.acs.org/doi/10.1021/ac… UCT IDM @UCT_News
'Our plans [for the future] are to catalyze job creation by driving the expansion of Africa’s #drugdiscovery community and ecosystem.' Dive into a wide-ranging interview with Kelly Chibale in the World Intellectual Property Organization (WIPO) Newsletter! wipo.int/wipo_magazine_…
Join us for our first webinar of the year on Wednesday, 14 February at 12PM
Dr Barry Hardy , Managing Director (CEO) at Edelweiss Connect, Switzerland will be discussing how integrated analysis can support prediction of drug adverse outcomes.
Webinar link: bit.ly/3wkdAHd
3 Months to go! Register now for the 5th H3D Symposium!
Abstract submission and travel bursary submission closes on 31st Jan 2024, don't miss your opportunity to present your research! linkedin.com/feed/update/ur…
#H3DSymposium #drugdiscovery
H3D is hiring! Are you interested in a microbiology Post-Doctoral Fellowship in Drug Metabolism? See below. #vacancies #drugdiscovery
H3D is hiring! Do you have a PhD in microbiology, molecular Biology, Biochemistry, Genetics or Cell Biology? See below for more information h3d.uct.ac.za/open-positions
#drugdiscovery #vacancies